Section 3: What is Hashimoto's Thyroiditis
Efficacy Zepbound is effective for managing chronic weight, obesity, and obstructive sleep apnea
Genetics and individual metabolism There is emerging evidence that genetic variations in GLP-1 receptor expression and sensitivity affect both the therapeutic response to semaglutide and the side effect profile
For participants enrolled in a clinical trial , the study team should be the first point of contact for any concerns about the medicine, its preparation, storage, or any symptoms experienced
NICE-SUGAR trial demonstrated increased mortality and 1015 higher severe hypoglycemia with strict 80110 mg/dL targets
The SELECT trial (Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity), a phase 3 study involving 17,604 adults with overweight or obesity and pre-existing CVD but no diabetes, revealed that once-weekly subcutaneous semaglutide 2.4 mg reduced the risk of major adverse cardiovascular events by 20% compared with placebo over a mean follow-up of 39.8 months, including cardiovascular death, nonfatal myocardial infarction, and nonfatal stroke [48]
